Top member reports
Company Report
Last edited 4 years ago
PerformanceCommunity EngagementCommunity Endorsement
ranked
#215
Performance (51m)
-15.4% pa
Followed by
156
Straws
Sort by:
Recent
Content is delayed by one month. Upgrade your membership to unlock all content. Click for membership options.
#Agreements & Pres 18/3/21
stale
Added 4 years ago

Oventus signs agreements with Connect DME and Circadian Australia (attached)

Key highlights:

  •  Virtual Lab in Lab agreement signed with Connect DME, a US-based national Durable Medical Equipment supplier which provides equipment directly to self-insured companies
  •  New distribution agreement signed with leading fatigue risk management group, Circadian Australia to offer Oventus devices to customers under the virtual Lab in Lab model

There were no $s mentioned in this announcement, but steps in rigt direction.

Oventus to present at virtual investor conference

Brisbane, Australia 18 March 2021: Obstructive Sleep Apnoea (OSA) treatment innovator, Oventus Medical Ltd or the Company (ASX: OVN), is pleased to share a copy of the investor presentation that it will present at the NWR Communications Virtual Investor Conference today.

The Company also invites investors to see Managing Director and CEO Chris Hart present an update at 10:45am AEDT.

Investors can register online to view the presentation go here:

https://us02web.zoom.us/webinar/register/WN_JkKiYlt5TDO5SIIm6g_lKg

For more information on the conference go here:      https://nwrconference.webflow.io/

For Full Presentation go here:

https://www.asx.com.au/asxpdf/20210318/pdf/44tsg4tzqcflbb.pdf

 

 

 

View Attachment

#H1FY21 Results 22/2/21
stale
Added 4 years ago

Oventus delivers H1 growth, launches US virtual Lab in Lab program; signs new sites and provides update on VGM agreement

Key highlights:

  •  H1 FY21 booked revenue up 192% vs the prior corresponding period (pcp) to A$550k and cash receipts up 109% to A$415k
  •  Strong quarter on quarter (QoQ) growth across all leading indicators since Sept 2020 quarter, despite COVID-19 driven interruptions
  •  New Lab in Lab contracts signed covering four additional sites – two of which are an extension to an earlier agreement with Canada’s Careica Health
  •  Including newly contracted sites and optimisation of existing agreements, 68 Lab in Lab sites are now contracted, 40 have launched and 24 are scanning
  •  Onboarding complete and the first member groups expected to go live under agreement with VGM & Associates in the next 90 days, ahead of timing expectations
  •  Homecare extension with dentist-guided remote impressions now successfully piloted in the direct-to-consumer market; launched in the US via website, GoPAPfree.com

View Attachment